Discovery of ML326: The first sub-micromolar, selective M5 PAM

Patrick R Gentry1, Thomas M Bridges, Atin Lamsal

  • 1Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Related Concept Videos